- Home
- APLD vs IBRX Comparison
APLD vs IBRX Comparison
Compare APLD & IBRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | APLD | IBRX |
|---|---|---|
| Founded | 2001 | 2014 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Investment Bankers/Brokers/Service | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 8.9B | 7.2B |
| IPO Year | 2021 | 2015 |
Fundamental Metrics
Financial Performance| Metric | APLD | IBRX |
|---|---|---|
| Price | $30.05 | $7.54 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 12 | 7 |
| Target Price | ★ $38.33 | $12.57 |
| AVG Volume (30 Days) | ★ 15.2M | 12.2M |
| Earning Date | 04-08-2026 | 05-08-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | 11.45 | ★ 38.71 |
| EPS | ★ N/A | N/A |
| Revenue | ★ $144,193,000.00 | $113,288,000.00 |
| Revenue This Year | $163.85 | $88.59 |
| Revenue Next Year | $64.81 | $131.15 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | ★ 668.31 |
| 52 Week Low | $9.79 | $1.95 |
| 52 Week High | $50.73 | $12.43 |
Technical Indicators
Market Signals| Indicator | APLD | IBRX |
|---|---|---|
| Relative Strength Index (RSI) | 41.03 | 44.85 |
| Support Level | $29.10 | $6.69 |
| Resistance Level | $36.86 | $8.54 |
| Average True Range (ATR) | 2.31 | 0.54 |
| MACD | -0.04 | -0.12 |
| Stochastic Oscillator | 52.25 | 12.61 |
Price Performance
Historical ComparisonAbout APLD Applied Digital Corporation
Applied Digital Corp is a designer, developer, and operator of next-generation digital infrastructure across North America. It provides digital infrastructure solutions and cloud services to industries like High-Performance Computing (HPC) and Artificial Intelligence (AI). The company operates in the following business segments: Data Center Hosting Business and HPC Hosting Business. The majority of its revenue is generated from the Data Center Hosting Business, which operates data centers to provide energized space to crypto mining customers.
About IBRX ImmunityBio Inc.
ImmunityBio Inc is a biotechnology company focused on developing and commercializing next-generation immunotherapies designed to activate the patient's immune system and provide durable protection against cancer and infectious diseases. Its approach harnesses both the adaptive and innate immune systems with the Cancer BioShield platform. The platform is built around the proprietary IL-15 superagonist ANKTIVA (nogapendekin alfa inbakicept) and is supported by a portfolio that includes adenovirus-vectored vaccines, NK-cell therapies, and additional immunomodulators. The company operates in the United States and Europe, with the majority of its revenue coming from the United States.